World News

EMA Recommends Granting a Marketing Authorisation for Elacestrant

Ogkologos - 26 Ιουλίου, 2023

Activity and Manageable Toxicity of Pembrolizumab in Some Rare and Ultrarare...

Ogkologos - 26 Ιουλίου, 2023

The Appraisal – Scientific disruption: what is it, and do we...

Ogkologos - 25 Ιουλίου, 2023

How People With Advanced Cancer Can Find Meaning Toward the End...

Ogkologos - 25 Ιουλίου, 2023

Durable Antitumour Activity of Pembrolizumab Plus Lenvatinib in Patients with Previously...

Ogkologos - 25 Ιουλίου, 2023

Maintenance Therapy Delays Cancer Growth for People With Advanced or Recurrent...

Ogkologos - 24 Ιουλίου, 2023

Durable Responses Observed in Patients with Papillary Craniopharyngiomas Tested Positive for...

Ogkologos - 24 Ιουλίου, 2023

Cancer-impacted mother becomes Times Square billboard to help child come across...

Ogkologos - 21 Ιουλίου, 2023

New on NCI’s Website for July 2023 – Researcher/Trainee Special Edition

Ogkologos - 21 Ιουλίου, 2023

First-Line Treatment with Atezolizumab Associated with Improved OS in Patients with...

Ogkologos - 21 Ιουλίου, 2023

1...118119120...432 Σελίδα 119 από 432

MOST POPULAR

Epcoritamab Shows a Manageable Safety and Robust Antitumour Activity in Heavily...

16 Σεπτεμβρίου, 2021

Keeping progress in oncology on the agenda: ESMO honours recipients of...

3 Δεκεμβρίου, 2020

Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with...

22 Νοεμβρίου, 2024

Nivolumab-Based Combinations Improve Survival in Advanced Esophageal Cancer

17 Ιουνίου, 2021

Φόρτωση περισσοτέρων

EMA Recommends Granting a Marketing Authorisation for Elacestrant

Activity and Manageable Toxicity of Pembrolizumab in Some Rare and Ultrarare...

The Appraisal – Scientific disruption: what is it, and do we...

How People With Advanced Cancer Can Find Meaning Toward the End...

Durable Antitumour Activity of Pembrolizumab Plus Lenvatinib in Patients with Previously...

Maintenance Therapy Delays Cancer Growth for People With Advanced or Recurrent...

Durable Responses Observed in Patients with Papillary Craniopharyngiomas Tested Positive for...

Cancer-impacted mother becomes Times Square billboard to help child come across...

New on NCI’s Website for July 2023 – Researcher/Trainee Special Edition

First-Line Treatment with Atezolizumab Associated with Improved OS in Patients with...

MOST POPULAR

Epcoritamab Shows a Manageable Safety and Robust Antitumour Activity in Heavily...

Keeping progress in oncology on the agenda: ESMO honours recipients of...

Neoadjuvant Nivolumab/Relatlimab Induces High Rates of Pathologic Responses in Patients with...

Nivolumab-Based Combinations Improve Survival in Advanced Esophageal Cancer

HOT NEWS

TRACERx: Using blood tests to track lung cancer

10 Tips for Healthy Eating After Cancer Treatment

EMA Recommends to Extend Therapeutic Indications for Crizotinib in Paediatric Patients

ALK Mutations and Amplifications are Independent Predictors of Poorer Survival in...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ